Definitive Contract 36C26321C0080

Award Date 7/16/21
Potential Completion Date 9/30/23
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs has awarded a Firm Fixed Price Definitive Contract worth $42,300.00 to Irepertoire Inc., a small disadvantaged business, to provide NWI RESEARCH - DR. MANON services. The contract has an ultimate completion date of August 31, 2024. Irepertoire Inc. is a for-profit organization that specializes in advanced molecular biology and immunological research services, with a focus on immune system analysis and sequencing technologies. The company has a strong track...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Definitive Contract to Irepertoire Inc., a self-certified small disadvantaged business, for $147,000.00. The contract, titled "IREPETOIRE SERVICES", is for the delivery of immune repertoire analysis services, including T-cell receptor deep sequencing, characterization of T-cell receptors, and other related research and laboratory testing services. The contract, which does not have a...
This is a $19,271.70 firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a self-certified small disadvantaged business. The contract is for immune repertoire sequencing services, with a completion date of July 8, 2024. Irepertoire Inc. has previously provided similar services to various HHS and Department of Veterans Affairs (VA)...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Irepertoire Inc., a self-certified small disadvantaged business, for PCR amplification services and sequencing services. The contract has a ceiling value of $22,932.00 and a period of performance through December 31, 2024. Irepertoire Inc. specializes in immune repertoire sequencing services, including T-cell receptor sequencing, to support research and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a self-certified small disadvantaged business. The $6,580 firm-fixed-price purchase order is for IPAIR Collaboration and Data Analysis Services, which likely involve T-cell receptor sequencing, RNA sequencing, PCR amplification, and related laboratory testing to support NIAID's research and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a small disadvantaged business, for RNA sequencing services for mouse T cell receptor research. The contract has a total ceiling value of $13,230.00 and a period of performance through February 28, 2025. Irepertoire Inc. will provide services such as T-cell receptor sequencing,...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Irepertoire Inc., a self-certified small disadvantaged business, for $61,965.00. The contract is for the delivery of IPAIR-REAGENTS, A2S-IPAIR, A2S-MI-V2, and IPAIR CAPTURE PLATE items, with data included at no additional cost. This purchase order is related to a prior pre-solicitation notice for a sole-source requirement...
This is a $87,442.00 firm fixed price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs to Proimmune, Inc., a for-profit company specializing in immunology research. The contract is for the allocation of laboratory time and delivery of reports, with a completion date of October 30, 2020. No set-aside was used for this award. Proimmune has previously provided various immunology research services to the Department of Health and...
This is a $80,536 firm fixed price definitive contract awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 5 to the Van Andel Research Institute (VAI), a non-profit biomedical research organization based in Grand Rapids, Michigan. The contract is for MIRECC (Mental Illness Research, Education and Clinical Center) research services, with a period of performance ending on September 30, 2021. VAI has previously received federal grants and contracts from...
This is a $98,253.09 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to CDI Laboratories Inc., a small disadvantaged business manufacturer. The contract is for the provision of CDI's HuProt v4.0 Human Proteome Microarray, containing over 21,000 human proteins, as well as its VirScan viral antibody profiling and immuneprofiler antibody analysis services. This work supports biomedical research efforts,...

This is a $42,700 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to Irepertoire Inc., a small disadvantaged business specializing in advanced molecular biology and immunological research services. The contract, which has no set-aside designation, is for VA NWI and University of Nebraska research. Irepertoire Inc. has a proven track record of securing federal research contracts from agencies such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), primarily focused on immunological, infectious disease, and cancer research efforts. The contract will run through September 30, 2023.

Generated 6/14/25, 11:05 AM